Template:Anticonvulsants: Difference between revisions
Content deleted Content added
DSisyphBot (talk | contribs) m r2.5.1) (Robot: Modifying fr:Modèle:Palette Antiépileptique |
use listclass = hlist in navbox as per WP:HLIST |
||
Line 2: | Line 2: | ||
| name = Anticonvulsants |
| name = Anticonvulsants |
||
| title = [[Anticonvulsant]]s ([[ATC_code_N03|N03]]) |
| title = [[Anticonvulsant]]s ([[ATC_code_N03|N03]]) |
||
|listclass = hlist |
|||
| groupstyle = background: LemonChiffon |
| groupstyle = background: LemonChiffon |
||
Line 9: | Line 10: | ||
| group1 = [[Barbiturate]]s |
| group1 = [[Barbiturate]]s |
||
| list1 = |
|||
| list1 = [[Barbexaclone]] • [[Metharbital]] • [[Methylphenobarbital]] • [[Pentobarbital]] • [[Phenobarbital]]<sup>#</sup> • [[Primidone]] |
|||
* [[Barbexaclone]] |
|||
* [[Metharbital]] |
|||
* [[Methylphenobarbital]] |
|||
* [[Pentobarbital]] |
|||
* [[Phenobarbital]]<sup>#</sup> |
|||
* [[Primidone]] |
|||
| group2 = [[Benzodiazepine]]s |
| group2 = [[Benzodiazepine]]s |
||
| list2 = |
|||
| list2 = [[Clobazam]] • [[Clonazepam]] • [[Clorazepate]] • [[Diazepam]]<sup>#</sup> • [[Flutoprazepam]] • [[Lorazepam]] • [[Midazolam]] • [[Nimetazepam]] • [[Nitrazepam]] • [[Temazepam]] |
|||
* [[Clobazam]] |
|||
* [[Clonazepam]] |
|||
* [[Clorazepate]] |
|||
* [[Diazepam]]<sup>#</sup> |
|||
* [[Flutoprazepam]] |
|||
* [[Lorazepam]] |
|||
* [[Midazolam]] |
|||
* [[Nimetazepam]] |
|||
* [[Nitrazepam]] |
|||
* [[Temazepam]] |
|||
Line 22: | Line 39: | ||
| group1 = [[Aromaticity|Aromatic]] [[allylic]] [[alcohol]]s |
| group1 = [[Aromaticity|Aromatic]] [[allylic]] [[alcohol]]s |
||
| list1 = [[Stiripentol]] |
| list1 = |
||
* [[Stiripentol]] |
|||
Line 32: | Line 50: | ||
| group1 = [[Sulfonamide (medicine)|Sulfa drug]]s |
| group1 = [[Sulfonamide (medicine)|Sulfa drug]]s |
||
| list1 = [[Acetazolamide]] |
| list1 = |
||
* [[Acetazolamide]] |
|||
* [[Ethoxzolamide]] |
|||
* [[Sultiame]] |
|||
* [[Zonisamide]] |
|||
}} |
}} |
||
Line 45: | Line 67: | ||
| group1 = [[Hydantoin]]s |
| group1 = [[Hydantoin]]s |
||
| list1 =[[Ethotoin]] |
| list1 = |
||
* [[Ethotoin]] |
|||
* [[Fosphenytoin]] |
|||
* [[Mephenytoin]] |
|||
* [[Phenytoin]]<sup>#</sup> |
|||
| group6 = [[Carboxamide]]s |
| group6 = [[Carboxamide]]s |
||
| list6 = |
|||
| list6 = [[Carbamazepine]]<sup>#</sup> • [[Eslicarbazepine acetate]] • [[Oxcarbazepine]] • [[Oxitriptyline]] • [[Rufinamide]] |
|||
* [[Carbamazepine]]<sup>#</sup> |
|||
* [[Eslicarbazepine acetate]] |
|||
* [[Oxcarbazepine]] |
|||
* [[Oxitriptyline]] |
|||
* [[Rufinamide]] |
|||
}} |
}} |
||
Line 57: | Line 88: | ||
| group4 = [[Succinimide]]s |
| group4 = [[Succinimide]]s |
||
| list4 = [[Ethosuximide]]<sup>#</sup> |
| list4 = |
||
* [[Ethosuximide]]<sup>#</sup> |
|||
* [[Mesuximide]] |
|||
* [[Phensuximide]] |
|||
}} |
}} |
||
|group3 = [[AMPA receptor]] |
|group3 = [[AMPA receptor]] |
||
|list3 = [[Perampanel]] |
|list3 = |
||
* [[Perampanel]] |
|||
|group4 = Unknown/ungrouped |
|group4 = Unknown/ungrouped |
||
|list4 = |
|||
|list4 = ''[[Phenyltriazine]]'' ([[Lamotrigine]]), ''[[Oxazolidinedione]]s'' ([[Ethadione]] • [[Paramethadione]] • [[Trimethadione]]), ''[[Urea]]s'' ([[Phenacemide]] • [[Pheneturide]]), ''[[Monosaccharide]]'' ([[Topiramate]]) |
|||
* ''[[Phenyltriazine]]'' ([[Lamotrigine]]), ''[[Oxazolidinedione]]s'' ([[Ethadione]] |
|||
* [[Paramethadione]] |
|||
* [[Trimethadione]]), ''[[Urea]]s'' ([[Phenacemide]] |
|||
* [[Pheneturide]]), ''[[Monosaccharide]]'' ([[Topiramate]]) |
|||
}} |
}} |
||
Line 74: | Line 113: | ||
| group1 = [[Potassium channel opener|Potassium]] |
| group1 = [[Potassium channel opener|Potassium]] |
||
| list1 = [[Retigabine]] |
| list1 = |
||
* [[Retigabine]] |
|||
}} |
}} |
||
Line 83: | Line 123: | ||
| group3 = [[Carboxylic acid]]s/<br />[[Fatty acid|Fatty acid derivatives]] |
| group3 = [[Carboxylic acid]]s/<br />[[Fatty acid|Fatty acid derivatives]] |
||
| list3 = |
|||
* [[GABA transaminase inhibitor]]: [[Valproic acid]]<sup>#</sup> ([[Sodium valproate]] & [[Valproate semisodium]]) |
|||
* [[Valpromide]] |
|||
* [[Valnoctamide]] |
|||
* [[Valproate pivoxil]] |
|||
[[GABA reuptake inhibitor]]: [[Tiagabine]] |
[[GABA reuptake inhibitor]]: [[Tiagabine]] |
||
| group8 = [[Gamma-Aminobutyric acid|GABA analog]]s |
| group8 = [[Gamma-Aminobutyric acid|GABA analog]]s |
||
| list8 = |
|||
| list8 = [[Gabapentin]] • [[Pregabalin]] • [[Progabide]] • [[Tolgabide]] • [[Vigabatrin]] |
|||
* [[Gabapentin]] |
|||
* [[Pregabalin]] |
|||
* [[Progabide]] |
|||
* [[Tolgabide]] |
|||
* [[Vigabatrin]] |
|||
}} |
}} |
||
Line 97: | Line 146: | ||
| group6 = [[Carbamate]]s |
| group6 = [[Carbamate]]s |
||
| list6 = [[Emylcamate]] |
| list6 = |
||
* [[Emylcamate]] |
|||
* [[Felbamate]] |
|||
* [[Meprobamate]] |
|||
* [[Carisbamate]] |
|||
| group7 = [[Pyrrolidine]]s |
| group7 = [[Pyrrolidine]]s |
||
| list7 = |
|||
| list7 = [[Brivaracetam]] • [[Levetiracetam]] • [[Nefiracetam]] • [[Seletracetam]] |
|||
* [[Brivaracetam]] |
|||
* [[Levetiracetam]] |
|||
* [[Nefiracetam]] |
|||
* [[Seletracetam]] |
|||
| group9 = [[Propanoate|Propionate]]s |
| group9 = [[Propanoate|Propionate]]s |
||
| list9 = [[Beclamide]] |
| list9 = |
||
* [[Beclamide]] |
|||
* [[Lacosamide]] |
|||
| group10 = [[Aldehyde]]s |
| group10 = [[Aldehyde]]s |
||
| list10 = [[Paraldehyde]] |
| list10 = |
||
* [[Paraldehyde]] |
|||
| group11 = [[Bromide]]s |
| group11 = [[Bromide]]s |
||
| list11 = [[Potassium bromide]] |
| list11 = |
||
* [[Potassium bromide]] |
|||
* [[Sodium bromide]] |
|||
Line 119: | Line 181: | ||
}}<noinclude> |
}}<noinclude> |
||
[[Category:Anticonvulsants]] |
[[Category:Anticonvulsants]] |
||
[[Category:Drug_templates by ATC |
[[Category:Drug_templates by ATC]] |
||
<!--fr:Modèle:Antiépileptique--> |
<!--fr:Modèle:Antiépileptique--> |
||
[[fr:Modèle:Palette Antiépileptique]] |
[[fr:Modèle:Palette Antiépileptique]] |